共 301 条
[21]
Vahdat LT(2015)FOXF2 suppresses the FOXC2-mediated epithelial–mesenchymal transition and multidrug resistance of basal-like breast cancer Cancer Lett 367 129-75
[22]
Altorki NK(2017)Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2 Cancer Lett 396 66-2720
[23]
Mittal V(2014)SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell Cell Signal 26 2710-50
[24]
Gao D(2016)Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer Cancer Treatment Rev 44 42-443
[25]
Singh A(2013)MiR-520 h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol Oncogene 32 431-94
[26]
Settleman J(2014)FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways Cancer Lett 353 87-535
[27]
Lazarova D(2008)The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy Annu Rev Pharmacol Toxicol 48 495-726
[28]
Bordonaro M(2013)Cancer drug resistance: an evolving paradigm Nat Rev Cancer 13 714-6
[29]
Wang X(2016)Transition to resistance: an unexpected role of the EMT in cancer chemoresistance Genes Dis 3 3-2360
[30]
Ling MT(2011)Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells Clin Cancer Res 17 2350-1403